Preliminary evaluation of the TB-IGRA VIRCLIA® Monotest chemiluminescent interferon-gamma release assay: a comparative agreement study with QuantiFERON-TB Gold Plus
Frontiers in Microbiology · 29.10.2026 · 17
DOI: 10.3389/fmicb.2026.1916499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.10.2026. Verfasst von Jose Mária Serrano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Service, Virgen de las Nieves University Hospital, Granada, Spain. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
We evaluated the qualitative and quantitative agreement of the novel chemiluminescent TB-IGRA VIRCLIA® Monotest with QuantiFERON®-TB Gold Plus (QFT-Plus) for detecting tuberculosis infection.
Methods
In this prospective comparative study, 226 consecutive samples submitted for routine tuberculosis infection testing were analyzed using the TB-IGRA VIRCLIA® Monotest and the QFT-Plus chemiluminescence immunoassay (CLIA). Agreement between the two tests was assessed by calculating the overall agreement, positive and negative percent agreement (PPA/NPA), Cohen’s kappa ( κ ), Deming regression, and Bland–Altman analysis. An exploratory QFT-Plus-derived borderline range (0.20–0.70 IU/mL) was analyzed separately. Additional quantitative analyses were performed after excluding observations at the QFT-Plus upper quantification limit (10 IU/mL).
Results
Overall qualitative agreement was 92.9% ( κ = 0.85; 95% confidence interval (CI), 0.79–0.92), with PPA of 90.1% (95% CI, 83.8–94.1) and NPA of 96.8% (95% CI, 91.1–98.9). Agreement was 94.25% for TB1 ( κ = 0.885; 95% CI, 0.824–0.945) and 89.82% for TB2 ( κ = 0.796; 95% CI, 0.718–0.875). In the borderline range, agreement decreased to 78.05% for TB1 ( κ = 0.529; 95% CI, 0.289–0.769) and 69.05% for TB2 ( κ = 0.316; 95% CI, 0.067–0.564), compared to 97.84 and 94.57%, respectively, for values outside this range. Deming regression slopes decreased from 3.085 to 0.811 for TB1 and from 3.146 to 0.926 for TB2 after excluding observations at the QFT-Plus upper quantification limit, with substantially narrower Bland–Altman limits of agreement.
Conclusion
The TB-IGRA VIRCLIA® Monotest showed a high overall qualitative agreement with QFT-Plus, particularly outside the borderline range. Agreement decreased near the positivity threshold, particularly for TB2, supporting cautious interpretation and potential repeat or confirmatory testing of borderline results. Quantitative comparisons at high interferon-gamma (IFN-γ) concentrations were substantially influenced by the QFT-Plus upper quantification limit.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microbiology Service, Virgen de las Nieves University Hospital, Granada, Spain.
- Clinical Medicine and Public Health Doctoral Program, Graduate School, University of Granada, Granada, Spain.
- Clinical Analysis and Immunology Service, Virgen de las Nieves University Hospital, Granada, Spain.
- Institute Biosanitary of Granada (ibs.GRANADA), Granada, Spain.
- Zaidin Sur Health Center, Andalusian Health Service, Granada, Spain.
- Department Medical Centre Penitentiary, Granada, Spain.
Zitieren
APA
Serrano, J. M., Aguilera-Franco, M., Gutiérrez-Bautista, J. F., Cobo, F., Olivares Duran, M. J., Sampedro-Padilla, A., Ruiz, F., Gutiérrez Fernández, J., Navarro-Mari, J. M., & Rodriguez-Granger, J. (2026). Preliminary evaluation of the TB-IGRA VIRCLIA® Monotest chemiluminescent interferon-gamma release assay: a comparative agreement study with QuantiFERON-TB Gold Plus. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1916499
Vancouver
Serrano JM, Aguilera-Franco M, Gutiérrez-Bautista JF, Cobo F, Olivares Duran MJ, Sampedro-Padilla A, et al. Preliminary evaluation of the TB-IGRA VIRCLIA® Monotest chemiluminescent interferon-gamma release assay: a comparative agreement study with QuantiFERON-TB Gold Plus. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1916499
BibTeX
@article{Serrano2026,
author = {Serrano, Jose Mária and Aguilera-Franco, Maria and Gutiérrez-Bautista, Juan Francisco and Cobo, Fernando and Olivares Duran, M J and Sampedro-Padilla, Antonio and Ruiz, F and Gutiérrez Fernández, Jose and Navarro-Mari, José María and Rodriguez-Granger, Javier},
title = {Preliminary evaluation of the TB-IGRA VIRCLIA® Monotest chemiluminescent interferon-gamma release assay: a comparative agreement study with QuantiFERON-TB Gold Plus},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1916499}
}
EUVIMED